$LITS

Glover Nicholas purchased $13K of LITS

Glover Nicholas purchased 2,000 shares of Lite Strategy, Inc. (LITS) at an average of $6.28 ($6.00–$6.55) across 2 trades over 2025-07-22 to 2025-07-23.

Original reporting
SEC EDGAR · Glover Nicholas
Published Oct 26, 2026, 9:44 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 26, 2026, 9:47 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$LITS
Neutral
low confidence
Mentioned
$LITS
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LITSNeutralLow
01

Why it matters

The transaction is modest in size and unlikely to affect market perception significantly.

02

Market read

Routine insider purchase with limited trading relevance.

03

What to watch

Potential upcoming corporate actions or financing that prompted the purchase.

Relevance 4/10Novelty 3/10Timing: after-hours filing today

Background

SEC Form 4 filings provide primary disclosure of insider transactions. This filing reports a director's purchase of 2,000 shares at an average price of $6.275.

Company-level read

Ticker impact

$LITSNeutralLow confidence
Context

Form 4 disclosed director Glover Nicholas bought 2,000 shares of Lite Strategy, Inc. for $12,550, a new insider purchase.

Expected impact

slight upward pressure as market prices in the buy signal

Evidence & confidence

Purchase size is trivial relative to market cap; no material impact expected.

Market effects

none

none

none

Counterpoint

Even small insider buys can precede larger moves if insider has material information.

Key entities

  • Lite Strategy, Inc.

    Micro‑cap listed on US exchanges under ticker LITS.

  • Glover Nicholas

    Director of Lite Strategy, Inc. who made the purchase.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LITSMed

Lite Strategy, Inc. (LITS): Results of Operations and Financial Condition

Lite Strategy, Inc. (LITS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Lite Strategy Repurchases 13% of Outstanding Shares Since December, Increasing Litecoin Backing Per Share Lite Strategy Buys Back Roughly 4.9 Million Shares at an Average Price of $1.11 with No Debt Incurred SAN DIEGO, July 30, 2026 — Lite Strategy, Inc. (Nasdaq: LITS) (“Lite Str

$LYCAMedAI 8/10

Venrock Healthcare Capital Partners III, L.P. (Koh Bong Y, Shah Nimish P) purchased $37.7M of LYCA (indirect holdings)

Venrock Healthcare Capital Partners III, L.P. purchased 2,045,440 indirectly-held shares of Lycia Therapeutics, Inc. (LYCA) at an average of $18.41 ($18.00–$26.97, $37.65M total) across 6 trades over 2026-10-23 to 2026-10-27. Filed jointly with VHCP Co-Investment Holdings III, LLC (10% owner), VHCP Management III, LLC (10% owner), Venrock Healthcare Capital Partners EG, L.P. (10% owner), VHCP Management EG, LLC (10% owner), Venrock Healthcare Capital Partners XP, L.P. (10% owner), VHCP Management XP, LLC (10% owner), Koh Bong Y (10% owner) and Shah Nimish P (10% owner).